Ada’s Clinical AI engages patients online as they search for answers—identifying likely conditions in minutes and surfacing high-value, hard-to-diagnose cases with the potential to cut years off the diagnostic journey.
Accurate
Built on a probabilistic model with 97% diagnostic accuracy—backed by 25+ peer-reviewed studies.
Trusted
Certified as a Class IIa medical device—meeting the rigorous standards expected by leading pharma and healthcare partners.
Measurable
From assessments to outcomes—see real-world impact through tokenization and downstream insights.
Ada surfaces and activates high-likelihood patients when they’re searching for answers—driving earlier diagnosis and meaningful action.
With token-based tracking, Ada connects awareness to outcomes—without compromising confidentiality.
Validated for Safety, Privacy, and Performance
EU-MDR
Class IIa Regulated Medical Device
US Food and Drug Administration
Ada operates under FDA enforcement discretion
HIPAA Compliant
US Health Insurance Portability and Accountability Act
ISO 13485
Certified quality management system
Connected digital health initiatives are a key step in lower cost, faster, more equitable, and more convenient access to healthcare… We are excited to be a part of this COVID-19 Care Journey and for its potential to help reach some of the most vulnerable patients across the United States
Our shared goal is to enable anyone to take more ownership of their health via credible, science-based information delivered through products they know and can rely on.
Our collaboration with Ada is designed to educate patients on high-risk factors for severe COVID-19 and introduce choices for people to access a provider and learn about treatment options.
Ada is a great mechanism for consumers to really critically assess and understand their symptoms and get clarity on what conditions they might be suffering from.
